We review the 2024 performance of both assets, the 2025 outlook, and some specific recommendations for investment in shares ...

Investing $1,000 a month with an average total return of 12% per annum would grow into $2.15 million after 27 years. That ...

Up 25% in 12 months, a leading fundie sees strong ongoing growth potential for this S&P/ASX 300 Index (ASX: XKO) stock.

Last week, the broker reaffirmed its buy rating and $40.20 price target on the ASX 200 share. This implies potential upside ...

Let's run the numbers and see how much an Australian investor would need in their superannuation fund to live off $65,000 a ...

The S&P/ASX 200 Index (ASX: XJO) is up 3% in 2025, with these three ASX 200 stocks doing a lot of the heavy lifting.

Goldman has a buy rating and $40.20 price target on its shares. Another ASX 200 share that is being described as a fallen ...

We reveal the forecast dividend amounts and dividend yields that analysts expect the largest ASX 200 financial shares to pay ...

In early trade, the ASX 200 biotech stock was up as much as 15% to $4.69. Its shares have since pulled back but remain up 3% ...

Kogan.com Ltd (ASX: KGN) and Regis Resources Ltd (ASX: RRL) are two of four ASX shares falling on Friday. Here's ...

Apple may not be the exciting growth stock it was years ago, but could the key to its long-term success depend on its services business?

The S&P/ASX 200 Index (ASX: XJO) lithium stock is enjoying a strong run after mothballing its lithium refinery expansion ...